Dual role of N-acetyl-aspartyl-glutamate metabolism in cancer monitor and therapy

Ryoichi Asaka, Anne Le

Research output: Contribution to journalArticlepeer-review

Abstract

We uncovered the neurotransmitter N-acetyl-aspartyl-glutamate (NAAG) as a reservoir providing glutamate to promote cancer growth, and demonstrated that inhibition of NAAG hydrolysis by targeting glutamate carboxypeptidase II is a viable strategy for cancer therapy. Our study also suggests that NAAG concentration in plasma could be a non-invasive measurement to monitor cancer progression.

Original languageEnglish (US)
Article numbere1627273
JournalMolecular and Cellular Oncology
Volume6
Issue number5
DOIs
StatePublished - 2019

Keywords

  • N-acetyl-aspartyl-glutamate (NAAG)
  • glutamate carboxypeptidase II (GCPII)
  • glutamate reservoir
  • glutaminase inhibitor
  • stable isotope-resolved metabolomics (SIRM)

ASJC Scopus subject areas

  • Molecular Medicine
  • Cancer Research

Fingerprint Dive into the research topics of 'Dual role of N-acetyl-aspartyl-glutamate metabolism in cancer monitor and therapy'. Together they form a unique fingerprint.

Cite this